CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

Mark S. Soloway, Joseph V. Briggman, Gennaro A. Carpinito et al. · The Journal of Urology · 1996 · 339 citations

Medicine, Oncology, Urology +16

Analysis of the performance of pathologists in the grading of bladder tumors

E. C. M. Ooms, Winston A. Anderson, C.L. Alons et al. · Human Pathology · 1983 · 261 citations

Medicine, Oncology, Pathology +12

Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer

Michael F. Sarosdy, Ralph W. deVere White, Mark S. Soloway et al. · The Journal of Urology · 1995 · 232 citations

Medicine, Oncology, Urology +10

Clinical Evaluation of Nuclear Matrix Protein 22 (NMP22) in Urine as a Novel Marker for Urothelial Cancer

Naoto Miyanaga, Hideyuki Akaza, Koji Kawai et al. · European Urology · 1997 · 128 citations

Medicine, Oncology, Urology +14

Initial Evaluation of the Bladder Tumor Antigen Test in Superficial Bladder Cancer

Marie‐Ange D’Hallewin, Luc Baert · The Journal of Urology · 1996 · 101 citations

Medicine, Oncology, Pathology +15